Skip to content

Optimizing HIV Virologic Outcomes for Pregnant Women in Uganda

Enhanced Viral Load Counseling and Standardized Peer Mother Support Study (ENHANCED-SPS)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04122144
Acronym
ENHANCED-SPS
Enrollment
980
Registered
2019-10-10
Start date
2019-09-19
Completion date
2022-09-19
Last updated
2019-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

pregnant woman

Brief summary

The ENHANCED -SPS study is a before and after cluster randomized trial that will be conducted in 14 public health facilities providing HIV care in Southwestern Uganda. The study will evaluate the effectiveness of a multi-component intervention package that targets barriers to achieving optimal viral suppression among pregnant and postpartum women infected with HIV. This will be in two phases; In Phase 1 (Before), all 14 clinics will have a baseline assessment of standard of care VL procedures and assess the barriers and facilitators to viral suppression for a period of 3 months. In Phase 2 (After), 7 clinics randomized to control arm will continue to experience standard of care counseling procedures, and 7 clinics randomized to intervention will initiate the ENHANCE-PS intervention. The Phase 2 (After) phase I will last at least 12 months.

Detailed description

The Investigators will test the hypothesis that the Enhanced viral load (VL) counseling and standardized peer mother support (ENHANCED-SPS) intervention will increase viral load suppression among HIV-infected pregnant and post-partum women and increase retention of mothers in care hence resulting in reduced risk of vertical transmission in south western Uganda. Specific objectives are as follows: 1\) To evaluate the effectiveness of an enhanced VL counseling and standardized peer mother support intervention on viral suppression among HIV infected pregnant women at 12 months of follow up; 2) To evaluate the effect of the enhanced counseling and peer support intervention on retention in care at 18 months postpartum follow up; The investigators will randomize 14 HIV clinics to the ENHANCED-SPS multi-component intervention vs. standard of care procedures (intervention=7 clinics and control=7 clinics,n=70 mothers/health facility) ;3) To assess the facilitators and barriers of VL and enhanced VL counseling and peer mother support intervention at 9 & 18 months of follow up.This will consider both patient and providers perspectives of the intervention implementation

Interventions

BEHAVIORALENHANCED -SPS intervention

a) Enhanced VL counseling: Explanation of VL & Importance of VL suppression,assessment of adherence, counseling based on VL result and schedule for next VL testing and the role of VL and the MTCT risk; b).Standardized peer mother support: includes training of peer mothers on mandatory enhanced VL counseling during the routine peer counseling and education, follow up of mothers and continued adherence counseling and disclosure support and bi-weekly phone calls to mothers to provide VL counseling and follow up

Sponsors

Infectious Diseases Research Collaboration, Uganda
CollaboratorOTHER
University of California, San Francisco
CollaboratorOTHER
Makerere University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Comparative effectiveness cluster-randomized trial

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. All Pregnant women and breastfeeding mothers enrolled in the mother baby care points/HIV clinics with documented HIV infection 2. . HIV infected Pregnant women reporting for their first ANC within the study clinics or newly identified HIV positive mothers from the ANC clinics/breastfeeding

Exclusion criteria

3. . All women who will be critically ill and unable to communicate 4. . Those not willing to consent to participate in the study 5. . Women who will not be able to understand all information concerning the study

Design outcomes

Primary

MeasureTime frameDescription
Viral suppression1 yearThe proportion of women with HIV-1 RNA suppression at 12 months of follow up to assess the effect of the intervention
Retention in care18 monthsThe proportion of women still in care at at 12 and 18 months postpartum

Secondary

MeasureTime frameDescription
Mother to child transmission rate18 monthsThe proportion of HIV free children born to the HIV positive mothers enrolled in the study at 18 months of follow up.

Countries

Uganda

Contacts

Primary ContactJane Kabami, MPH
kabajane@yahoo.com+256776411044
Backup ContactMoses Kamya, PhD
mkamya@infocom.co.ug+256752900012

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026